ZebraEye
AI diagnostics of rare eye diseases using OCT scans. Founded in 2023 by Yana Ten, Arman Ospanov, and Doszhan Zhusupov; focused on the Chinese market per statement on 16.04.2026.
About
ZebraEye is a Kazakhstani medical AI startup in ophthalmology developing artificial intelligence software for the early diagnosis of rare eye pathologies from optical coherence tomography (OCT) scans. The company was founded in 2023 in Almaty by Yana Ten (CEO), Arman Ospanov, and Doszhan Zhusupov. In an interview with Forbes Kazakhstan on 26.07.2024, the founder reported that total investment in development amounted to approximately $300,000, including personal contributions from the founders (Arman Ospanov, Doszhan Zhusupov, Yana Ten) and funds from private investors (the exact equity breakdown and valuation were not disclosed). According to an interview with Yana Ten published by The Tech on 16.04.2026, the project went through a crisis and was relaunched with a pivot toward the Chinese market in partnership with the Khan Tengri Innovation Hub in Shanghai; earlier plans for CE/FDA certification and current fundraising needs are under editorial review.
Founders
Team information is compiled from open sources and may be updated by our editors.
RAEM Coverage
Profile history
Sources
- Top 7 MedTech Startups in Kazakhstan: How Artificial Intelligence and Tech Are Saving Lives ↗RAEM.KZ publication
- Яна Тен: её AI для диагностики редких болезней глаз встал на паузу, а вернул его спрос из Китая ↗RAEM.KZ publication
- Founder interview (Forbes Kazakhstan) ↗ Published: 26.07.2024 (~$300K investment)
- Forbes Kazakhstan (26.07.2024) | The Tech (16.04.2026) | zebraeye.ai Recorded by editors
- Official website ↗Primary source
Is this your company?
Verify that you represent ZebraEye to update this profile and receive inquiries from investors and partners.
Similar startups
All in sector →
Automated medical examination complexes (ASMO) for 1-minute express employee checkups at industrial sites. Winner of the Altyn Sapa 2023 award.
Robotic glove with a brain-computer interface for post-stroke rehabilitation developed by a high school team at NIS Shymkent.

Smart nano-insoles with biosensors for rehabilitation and sports. Disclosed investment by JAS Ventures Limited — $110K (announced Aug 2025, published Dec 2025).

Kazakhstani digital medication search engine and pharmacy aggregator. Legal entity: Unified Reference Service I-teka LLP. Venture studio project by Activat VC. CEO: Zhuldyzai Seidalina. Public valuation unconfirmed.